130 related items for PubMed ID: 10818284
1. Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone.
Heuser I, Deuschle M, Weber B, Stalla GK, Holsboer F.
Psychoneuroendocrinology; 2000 Jul; 25(5):513-8. PubMed ID: 10818284
[Abstract] [Full Text] [Related]
2. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
Berardelli R, Karamouzis I, Marinazzo E, Prats E, Picu A, Giordano R, Ghigo E, Arvat E.
Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855
[Abstract] [Full Text] [Related]
3. Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humans.
Deuschle M, Weber B, Colla M, Müller M, Kniest A, Heuser I.
Neuroendocrinology; 1998 Nov; 68(5):355-60. PubMed ID: 9822803
[Abstract] [Full Text] [Related]
4. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
Grottoli S, Giordano R, Maccagno B, Pellegrino M, Ghigo E, Arvat E.
J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
[Abstract] [Full Text] [Related]
5. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans.
Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H.
J Clin Endocrinol Metab; 1998 Sep; 83(9):3339-45. PubMed ID: 9745451
[Abstract] [Full Text] [Related]
6. Increased neuroendocrine reactivity and decreased brain mineralocorticoid receptor-binding capacity in aged dogs.
Rothuizen J, Reul JM, van Sluijs FJ, Mol JA, Rijnberk A, de Kloet ER.
Endocrinology; 1993 Jan; 132(1):161-8. PubMed ID: 8380372
[Abstract] [Full Text] [Related]
7. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
Arvat E, Maccagno B, Giordano R, Pellegrino M, Broglio F, Gianotti L, Maccario M, Camanni F, Ghigo E.
J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
[Abstract] [Full Text] [Related]
8. The role of mineralocorticoid receptors in the circadian activity of the human hypothalamus-pituitary-adrenal system: effect of age.
Heuser I, Deuschle M, Weber A, Kniest A, Ziegler C, Weber B, Colla M.
Neurobiol Aging; 2000 Jul; 21(4):585-9. PubMed ID: 10924776
[Abstract] [Full Text] [Related]
9. Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging.
Hatzinger M, Reul JM, Landgraf R, Holsboer F, Neumann I.
Neuroendocrinology; 1996 Nov; 64(5):349-56. PubMed ID: 8930935
[Abstract] [Full Text] [Related]
10. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
Reincke M, Allolio B, Würth G, Winkelmann W.
J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
[Abstract] [Full Text] [Related]
11. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
Calogero AE, Kamilaris TC, Johnson EO, Tartaglia ME, Chrousos G.
Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
[Abstract] [Full Text] [Related]
12. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone.
Gesing A, Bilang-Bleuel A, Droste SK, Linthorst AC, Holsboer F, Reul JM.
J Neurosci; 2001 Jul 01; 21(13):4822-9. PubMed ID: 11425909
[Abstract] [Full Text] [Related]
13. Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.
Mattsson C, Reynolds RM, Simonyte K, Olsson T, Walker BR.
J Clin Endocrinol Metab; 2009 Apr 01; 94(4):1347-52. PubMed ID: 19141586
[Abstract] [Full Text] [Related]
14. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
Kudielka BM, Schmidt-Reinwald AK, Hellhammer DH, Kirschbaum C.
Neuroendocrinology; 1999 Dec 01; 70(6):422-30. PubMed ID: 10657735
[Abstract] [Full Text] [Related]
15. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis.
Oitzl MS, van Haarst AD, Sutanto W, de Kloet ER.
Psychoneuroendocrinology; 1995 Dec 01; 20(6):655-75. PubMed ID: 8584606
[Abstract] [Full Text] [Related]
16. Effects of prenatal ethanol exposure on basal limbic-hypothalamic-pituitary-adrenal regulation: role of corticosterone.
Glavas MM, Ellis L, Yu WK, Weinberg J.
Alcohol Clin Exp Res; 2007 Sep 01; 31(9):1598-610. PubMed ID: 17760789
[Abstract] [Full Text] [Related]
17. Effect of antalarmin, a novel corticotropin-releasing hormone antagonist, on the dynamic function of the preterm ovine fetal hypothalamo-pituitary-adrenal axis.
Young IR, Chan EC, Smith R, Chrousos GP, Veldhuis JD, Canny BJ.
Neuroendocrinology; 2002 Jul 01; 76(1):47-54. PubMed ID: 12097816
[Abstract] [Full Text] [Related]
18. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
Huang TS.
J Endocrinol Invest; 1997 Jul 01; 20(7):393-6. PubMed ID: 9309537
[Abstract] [Full Text] [Related]
19. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.
Giordano R, Bo M, Pellegrino M, Vezzari M, Baldi M, Picu A, Balbo M, Bonelli L, Migliaretti G, Ghigo E, Arvat E.
J Clin Endocrinol Metab; 2005 Oct 01; 90(10):5656-62. PubMed ID: 16014406
[Abstract] [Full Text] [Related]
20. Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function and blood pressure in mature male guinea pigs.
Banjanin S, Kapoor A, Matthews SG.
J Physiol; 2004 Jul 01; 558(Pt 1):305-18. PubMed ID: 15146051
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
